Recent News

By Region: North America

Pentagon Funds Development of Ebola, Marburg Treatments

The U.S. Defense Department last week issued a new contract worth as much as $291 million for advanced work on two possible medical treatments for the Marburg and Ebola viruses.

July 20, 2010
| Filed under North America and Research
Share

Vaccine-delivery patch with dissolving microneedles eliminates ‘sharps,’ boosts protection

A new vaccine-delivery patch based on hundreds of microscopic needles that dissolve into the skin could allow persons without medical training to painlessly administer vaccines while providing improved immunization against diseases such as influenza.

July 19, 2010
| Filed under North America, Countermeasures, and Public Health
Share

U.S. Congress fails to pass WMD legislation – Examiner.com

Examiner.comU.S. Congress fails to pass WMD legislationExaminer.comCalling the legislation a "comprehensive approach to improving America's biodefense capabilities," WMD Commission Chair, Sen. Bob Graham, and Vice-Chair, …and more »

July 17, 2010
| Filed under North America and Research
Share

PharmAthene Presents New Data For Lyophilized RPA Anthrax Vaccine Showing Enhanced Immunogenicity

PharmAthene Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced results from a New Zealand White Rabbit study showing that its lyophilized recombinant Protective Antigen (rPA) anthrax vaccine was more immunogenic than a liquid formulation of rPA vaccine and produced a robust response with only 2 doses…

July 16, 2010
| Filed under North America and Research
Share

Worker Protection From Pathogens Said Key in Bioterror Response

Adequate protections from airborne pathogens are crucial in protectiong health workers and other responders from infection in the event of a disease outbreak or bioterror attack, U.S. government researchers said yesterday.